Hima Medical (03309.HK) received an increase in shareholding of 1.004 million shares from Chairman, CEO and Executive Director Lin Shunchao.

Gelonghui Finance · Sep 17 07:25

According to the latest equity disclosure data from the Stock Exchange of Hong Kong, from September 12 to September 16, 2024, Hyloma Medical (03309.HK) chairman, CEO, and executive director Lin Shunchao increased his shareholding by acquiring 1.004 million shares at an average price per share of HK$2.0308-2.0571, with a total investment of approximately HK$2.05 million.

After the increase in shareholding, Lin Shunchao's latest shareholding is 691,616,553 shares, and the shareholding ratio has increased from 55.00% to 55.08%.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

希玛医疗(03309.HK)获主席、行政总裁兼执行董事林顺潮增持100.4万股

Hima Medical (03309.HK) received an increase in shareholding of 1.004 million shares from Chairman, CEO and Executive Director Lin Shunchao.

Risk Disclaimer

Statement